Skip to content
Screener

Thermo Fisher Scientific TMO Life Sciences Solutions — Acquisitions

Other segment segments

Laboratory Products and Biopharma Services
$15M
Analytical Instruments
$0
Specialty Diagnostics
$0

Similar metrics at other companies

Horace Mann Educators logo
HMNLife & Retirement — Acquisitions
$0
ABM Industries logo
ABMTechnical Solutions — Acquisitions
$3.68M-81.8%
JBT Marel Corporation logo
JBTMProtein Solutions — Acquisitions
$0
Vontier logo
VNTRepair Solutions — Acquisitions
$0
CRH logo
CRHInternational Solutions — Acquisitions
$15M-54.5%
Casella Waste Systems logo
CWSTResource Solutions — Acquisitions
$0-100%

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$213.65B+26.0%
Enterprise value$248.77B+22.9%
P/E30.7×+4.9×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The source filing: Thermo Fisher Scientific’s 10-K, filed February 26, 2026.

Filed
Feb 26, 2026, 12:11 PM EST
Fiscal year
FY2025
Accession
0000097745-26-000018
(In millions)Life Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma ServicesTotal
Balance at December 31, 2023$10,151$5,051$4,923$23,895$44,020
Acquisitions2,3022,302
Currency translation(117)(92)(139)(122)(470)
Balance at December 31, 202412,3364,9594,78423,77345,853
Acquisitions2,101152,117
Currency translation4731842924441,393
Balance at December 31, 2025$14,910$5,143$5,076$24,232$49,362

Item 8. Financial Statements and Supplementary Data

FAQ

What is Thermo Fisher Scientific's life sciences solutions — acquisitions?
Thermo Fisher Scientific (TMO) reported life sciences solutions — acquisitions of $525.25M in Q4 2025.
How has Thermo Fisher Scientific's life sciences solutions — acquisitions changed year-over-year?
Thermo Fisher Scientific's life sciences solutions — acquisitions decreased by 8.7% year-over-year, from $575.5M to $525.25M.
What is the long-term trend for Thermo Fisher Scientific's life sciences solutions — acquisitions?
Over 4 years (2021 to 2025), Thermo Fisher Scientific's life sciences solutions — acquisitions has grown at a 7.7% compound annual growth rate (CAGR), from $1.56B to $2.1B.
What does life sciences solutions — acquisitions mean?
The total capital deployed by the Life Sciences Solutions segment to purchase other companies or business units. This metric tracks the inorganic growth strategy and the integration of new technologies or product lines into the existing portfolio.

Ask your AI about Thermo Fisher Scientific's life sciences solutions — acquisitions.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude